Related references
Note: Only part of the references are listed.Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort
Alexandra Smith et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2018)
Impact of age and socioeconomic status on treatment and survival from aggressive lymphoma: a UK population-based study of diffuse large B-cell lymphoma
Alexandra Smith et al.
CANCER EPIDEMIOLOGY (2015)
Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies
David W. Scott et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Transferring genomics to the clinic: distinguishing Burkitt and diffuse large B cell lymphomas
Chulin Sha et al.
GENOME MEDICINE (2015)
A Microarray Platform-Independent Classification Tool for Cell of Origin Class Allows Comparative Analysis of Gene Expression in Diffuse Large B-cell Lymphoma
Matthew A. Care et al.
PLOS ONE (2013)
Whole genome expression profiling based on paraffin embedded tissue can be used to classify diffuse large B-cell lymphoma and predict clinical outcome
Sharon L. Barrans et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Molecular diagnosis of Burkitt's lymphoma
Sandeep S. Dave et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling
Michael Hummel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Share Paper
